Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer.
Saved in:
| Title: | Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. |
|---|---|
| Authors: | Laheurte C; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France., Dosset M; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France., Vernerey D; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; Department of medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, F-25000, Besançon, France., Boullerot L; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France., Gaugler B; UPMC Univ Paris 06, INSERM UMR 938, Centre de Recherche Saint-Antoine, Sorbonne Universités, F-75012, Paris, France., Gravelin E; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France., Kaulek V; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France., Jacquin M; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France., Cuche L; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France., Eberst G; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France., Jacoulet P; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France., Fabre E; Department of medical Oncology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France., Le Pimpec-Barthes F; Department of Thoracic surgery, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France., Tartour E; Department of Biological Immuology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France., De Carvalho Bittencourt M; University Hospital of Nancy and CECITA team, IMOPA UMR7365 University of Lorraine/CNRS, Laboratory of Immunology, Vandoeuvre-les-Nancy, France., Westeel V; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France., Adotévi O; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France. olivier.adotevi@univ-fcomte.fr.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France. olivier.adotevi@univ-fcomte.fr.; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France. olivier.adotevi@univ-fcomte.fr. |
| Source: | British journal of cancer [Br J Cancer] 2019 Aug; Vol. 121 (5), pp. 405-416. Date of Electronic Publication: 2019 Jul 30. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31358938 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Distinct prognostic value of circulating anti-telomerase CD4<superscript>+</superscript> Th1 immunity and exhausted PD-1<superscript>+</superscript>/TIM-3<superscript>+</superscript> T cells in lung cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Laheurte+C%22">Laheurte C</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Dosset+M%22">Dosset M</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Vernerey+D%22">Vernerey D</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; Department of medical Oncology, Methodology and Quality of Life Unit in Oncology, University Hospital of Besançon, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Boullerot+L%22">Boullerot L</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Gaugler+B%22">Gaugler B</searchLink>; UPMC Univ Paris 06, INSERM UMR 938, Centre de Recherche Saint-Antoine, Sorbonne Universités, F-75012, Paris, France.<br /><searchLink fieldCode="AU" term="%22Gravelin+E%22">Gravelin E</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Kaulek+V%22">Kaulek V</searchLink>; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Jacquin+M%22">Jacquin M</searchLink>; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Cuche+L%22">Cuche L</searchLink>; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Eberst+G%22">Eberst G</searchLink>; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Jacoulet+P%22">Jacoulet P</searchLink>; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Fabre+E%22">Fabre E</searchLink>; Department of medical Oncology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.<br /><searchLink fieldCode="AU" term="%22Le+Pimpec-Barthes+F%22">Le Pimpec-Barthes F</searchLink>; Department of Thoracic surgery, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tartour+E%22">Tartour E</searchLink>; Department of Biological Immuology, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.<br /><searchLink fieldCode="AU" term="%22De+Carvalho+Bittencourt+M%22">De Carvalho Bittencourt M</searchLink>; University Hospital of Nancy and CECITA team, IMOPA UMR7365 University of Lorraine/CNRS, Laboratory of Immunology, Vandoeuvre-les-Nancy, France.<br /><searchLink fieldCode="AU" term="%22Westeel+V%22">Westeel V</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France.; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France.<br /><searchLink fieldCode="AU" term="%22Adotévi+O%22">Adotévi O</searchLink>; University Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, F-25000, Besançon, France. olivier.adotevi@univ-fcomte.fr.; INSERM CIC-1431, Clinical Investigation Center in Biotherapy, Plateforme de Biomonitoring, F-25000, Besançon, France. olivier.adotevi@univ-fcomte.fr.; Department of Pneumology, University Hospital of Besançon, F-25000, Besançon, France. olivier.adotevi@univ-fcomte.fr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2019 Aug; Vol. 121 (5), pp. 405-416. <i>Date of Electronic Publication: </i>2019 Jul 30. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31358938 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41416-019-0531-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 405 Titles: – TitleFull: Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Laheurte C – PersonEntity: Name: NameFull: Dosset M – PersonEntity: Name: NameFull: Vernerey D – PersonEntity: Name: NameFull: Boullerot L – PersonEntity: Name: NameFull: Gaugler B – PersonEntity: Name: NameFull: Gravelin E – PersonEntity: Name: NameFull: Kaulek V – PersonEntity: Name: NameFull: Jacquin M – PersonEntity: Name: NameFull: Cuche L – PersonEntity: Name: NameFull: Eberst G – PersonEntity: Name: NameFull: Jacoulet P – PersonEntity: Name: NameFull: Fabre E – PersonEntity: Name: NameFull: Le Pimpec-Barthes F – PersonEntity: Name: NameFull: Tartour E – PersonEntity: Name: NameFull: De Carvalho Bittencourt M – PersonEntity: Name: NameFull: Westeel V – PersonEntity: Name: NameFull: Adotévi O IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2019 Aug Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1532-1827 Numbering: – Type: volume Value: 121 – Type: issue Value: 5 Titles: – TitleFull: British journal of cancer Type: main |
| ResultId | 1 |